-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Minimed Group, Raises Price Target to $26

Benzinga·09/02/2026 18:47:17
Listen to the news
Citigroup analyst Joanne Wuensch maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price target from $23 to $26.